| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.66B | 29.59B | 28.65B | 26.77B | 19.20B | 13.12B |
| Gross Profit | 14.46B | 14.39B | 14.67B | 14.74B | 13.24B | 10.25B |
| EBITDA | 9.36B | 9.41B | 9.27B | 8.16B | 7.29B | 5.37B |
| Net Income | 5.58B | 5.63B | 5.46B | 4.91B | 4.47B | 3.19B |
Balance Sheet | ||||||
| Total Assets | 554.37B | 551.17B | 485.64B | 448.20B | 428.29B | 392.27B |
| Cash, Cash Equivalents and Short-Term Investments | 74.96B | 100.43B | 82.64B | 85.96B | 93.67B | 95.27B |
| Total Debt | 44.72B | 43.05B | 40.18B | 37.81B | 34.07B | 38.66B |
| Total Liabilities | 517.46B | 514.75B | 452.91B | 419.50B | 403.42B | 370.54B |
| Stockholders Equity | 35.25B | 34.77B | 31.29B | 27.46B | 23.78B | 20.77B |
Cash Flow | ||||||
| Free Cash Flow | 12.76B | 16.08B | 13.77B | 3.09B | 3.51B | 3.79B |
| Operating Cash Flow | 13.39B | 16.68B | 14.38B | 3.53B | 3.90B | 4.13B |
| Investing Cash Flow | -57.65B | -57.10B | -43.35B | -20.46B | -34.40B | -25.12B |
| Financing Cash Flow | 33.36B | 41.36B | 25.08B | 9.84B | 28.24B | 30.24B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | ₪59.38B | 10.63 | 16.87% | 4.11% | 12.78% | 1.42% | |
70 Outperform | ₪110.13B | 10.89 | 15.67% | 3.70% | 17.99% | 9.86% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | ₪101.07B | 10.78 | 15.13% | 3.54% | 20.24% | 17.76% | |
64 Neutral | ₪39.74B | 9.91 | 13.10% | 3.69% | 22.83% | -5.05% | |
58 Neutral | ₪24.69B | 11.18 | 15.81% | 4.57% | 21.26% | -5.22% |